美国阿巴拉契亚地区注射吸毒相关致死性过量、急性病毒性肝炎与HIV(2000-2023)
该研究分析了美国阿巴拉契亚各次区域2000-2023年致死性药物过量、甲肝、急性乙肝、急性丙肝的年发病率,以及2008-2023年≥15岁人群注射吸毒归因HIV诊断率。中阿巴拉契亚次区域上述疾病率较2000年峰值分别升高985%、2173%、223%、336%,HIV新诊断率较2008年升高380%。所有疾病率在阿巴拉契亚地区高于非阿巴拉契亚美国,尤以中及中北阿巴拉契亚25-44岁成人为著。
要点
- 中阿巴拉契亚次区域致死性过量、甲肝、急性乙肝、急性丙肝率较2000年峰值大幅上升。
- 注射吸毒归因HIV新诊断率在2008-2023年间峰值较2008年升高380%。
- 阿巴拉契亚地区所有疾病率高于非阿巴拉契亚美国,25-44岁成人负担最重。
核心结论
- 中阿巴拉契亚次区域在经济困境背景下,致死性药物过量与传染病发病率显著升高,尤其在育龄工作年龄成人中。
- 需针对健康社会决定因素并扩大综合医疗、物质使用障碍治疗、过量预防和针具服务以控制该综合征流行。
研究设计与样本
- 研究计算了美国、非阿巴拉契亚美国及阿巴拉契亚次区域2000-2023年每10万人口年发病率,涵盖非故意和未确定致死性过量、甲肝、急性乙肝、急性丙肝。
- 研究还计算了2008-2023年≥15岁人群注射吸毒归因HIV诊断率,以及2014-2023年所有疾病的年龄和性别别发病率。
主要发现
- 2000-2023年中阿巴拉契亚次区域年龄调整致死性药物过量、甲肝、急性乙肝、急性丙肝率峰值分别较2000年率升高985%、2173%、223%、336%。
- 2008-2023年注射吸毒归因HIV新感染率峰值较2008年率升高380%。
- 所有疾病率在阿巴拉契亚地区高于非阿巴拉契亚美国,尤其在中及中北阿巴拉契亚次区域25-44岁成人中。
临床怎么用
- 临床应关注阿巴拉契亚地区工作年龄成人中注射吸毒相关传染病与过量风险,整合筛查与预防服务。
- 扩大综合医疗、物质使用障碍治疗、过量预防和针具服务是控制该综合征的关键干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Appalachian states are disproportionately impacted by poverty, high rates of fatal overdose, hepatitis A, acute hepatitis B, acute hepatitis C, and human immunodeficiency virus (HIV). We evaluated trends for these syndemic conditions by Appalachian subregion to better inform prevention measures. METHODS: For the United States, non-Appalachian United States and Appalachian subregions, we calculated annual rates per 100 000 population for unintentional and undetermined fatal overdoses, hepatitis A, acute hepatitis B and acute hepatitis C during 2000-2023; and diagnoses of HIV for persons aged ≥ 15 years attributed to injection drug use (IDU) during 2008-2023. We calculated age and sex-specific rates during 2014-2023 for all diseases and conditions. RESULTS: During 2000-2023 in the central Appalachian subregions, age-adjusted rates of fatal drug overdose, hepatitis A, acute hepatitis B, and acute hepatitis C peaked at 985%, 2173%, 223% and 336% over the year 2000 rates. During 2008-2023, rates of new HIV infections attributable to IDU peaked at 380% over year 2008 rates. Rates of all conditions were higher in the Appalachian Region than in the non-Appalachian USA, especially in adults aged 25-44 years in Central and North Central Appalachian subregions. CONCLUSIONS: We documented elevated rates of infectious diseases and fatal drug overdose against a background of increased economic distress in the central Appalachian subregions, especially among working-age adults of reproductive age. Interventions to address social determinants of health and expand access to comprehensive integrated medical and substance use disorder treatment, overdose prevention, and syringe services are critical to control this syndemic.
引用
- Bixler D, Bennett CC, Yin S, et al. Fatal Overdose, Acute Viral Hepatitis, and HIV Attributed to Injection Drug Use, Appalachian Region of the United States, 2000-2023. Clin Infect Dis. 2026. PMID: 41670441. doi:10.1093/cid/ciaf730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。